Dispersome IP ApS
CVR 44931478 · Private limited company (ApS) · Active · Medium risk
Dispersome IP ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 2.6% over the next 12 months, which is 1.9 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Mar 2026) shows equity of DKK -4.5m and a net result of DKK -21.6m. CEO: Christoph Brücher.
Bankruptcy risk for Dispersome IP ApS
1.9 × the average (1.41%) · higher risk than 86% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44931478
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Fruebjergvej 3
2100 København Ø - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -704.2% |
| Current ratio | 12% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 611 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2026 | 2025 |
|---|---|---|
| Gross profit | DKK -1.4m | DKK -1.9m |
| Net profit | DKK -21.6m | DKK -2.3m |
| Equity | DKK -4.5m | DKK 17.1m |
| Total assets | DKK 640k | DKK 25.2m |
| Cash | DKK 621k | DKK 1.4m |
| Short-term debt | DKK 5.1m | DKK 3.3m |
| Avg. employees | 0 | 0 |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 69 | ||
| 27 Jun 2024 – 31 Mar 2025 | 72 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Christoph Brücher | Current | |
| CEO | Ole Sylvester-Hvid Wiborg | ||
| Board | Ole Sylvester-Hvid Wiborg | Current | |
| Board | Korbinian Arthur Maria Löbmann | Current | |
| Board | Christoph Brücher | Current | |
| Board | Márcio Milton Nunes Temtem | Current | |
| Board | Ole Sylvester-Hvid Wiborg | ||
| Board | Jakob Dynnes Hansen | ||
| Owner (50%) | Zerion Pharma A/S | Current | |
| Owner (50%) | HOVIONE FARMACIÊNCIA, S.A. | Current | |
| Owner (100%) | Zerion Pharma A/S | ||
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Zerion Pharma A/S | Current |
The CEOs' other companies
Ole Sylvester-Hvid Wiborg – 7 other companies, of which 2 bankrupt
- CYTOVAC A/S Bankrupt 18 Mar 2025
- PLEXUS DANMARK ApS Bankrupt 25 Jan 2005
- CENGENT THERAPEUTICS EUROPE A/S Opløst
- Cura Nordic ApS Opløst
- WIBORG ApS Active
- ZIMPL ApS Active
- Zerion Pharma A/S Active
Address history (0 moves)
| Fruebjergvej 3, 2100 København Ø |
Other companies at the same address
- A DIMENSION GROUP A/S Bankrupt
- A-SYNTESE BIOTECH ApS Bankrupt
- ABSTRACTION ApS Bankrupt
- ADURA ApS Bankrupt
- AFVIKLINGSSELSKABET AF 8.2.1999 A/S Bankrupt
- ALLEGENETICS DIAGNOSTICS LABORATORY ApS Bankrupt
- ANSARI GROUP S.M.B.A. Bankrupt
- AQUALIFE A/S Bankrupt
- AREA NETWORKS ApS Bankrupt
- ASD Group Denmark ApS Bankrupt
- Afsluttet Projektselskab BLN ApS Bankrupt
- Andersen & Andersen IVS Bankrupt
- Andersentraveller ApS Bankrupt
- ApS VICTORIA STREET KOMPLEMENTAR Bankrupt
- Autocycle International ApS Bankrupt
- BB Ejendomme 2015 IVS Bankrupt
- BB Jyllands investering IVS Bankrupt
- BB Jyllands projekt IVS Bankrupt
- BINCORE GROUP A/S Bankrupt
- BINCORE INDUSTRIES A/S Bankrupt
- BLUSENSE DIAGNOSTICS APS Bankrupt
- BRUUNS INVEST ApS Bankrupt
- BRUUNS REVISION ApS Bankrupt
- BUILD ApS Bankrupt
- Baunsgaard Technologies ApS Bankrupt
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
- Linker Pharmaceuticals ApS København K
Questions and answers about Dispersome IP ApS
Has Dispersome IP ApS gone bankrupt?
No, Dispersome IP ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Dispersome IP ApS?
Our model estimates a bankruptcy risk of 2.6% over the next 12 months (medium risk), which is 1.9 times the average for Danish companies.
Who is the CEO of Dispersome IP ApS?
Christoph Brücher is the CEO of Dispersome IP ApS.
Who is the auditor of Dispersome IP ApS?
Dispersome IP ApS most recently used Cedra Godkendt Revisionsaktieselskab.
When was Dispersome IP ApS founded?
Dispersome IP ApS was founded on 27 June 2024.
What is the equity of Dispersome IP ApS?
Equity was DKK -4.5m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.